Common Equity: The sum of all common equity items.
Yubo International Biotech Limited (YBGJ) had Common Equity of $-2.31M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.27M |
|
-- |
|
-- |
|
$0.29M |
|
$-0.29M |
|
$-0.01M |
|
$-0.29M |
|
$-0.29M |
|
$-0.29M |
|
$-0.29M |
|
$-0.29M |
|
$-0.29M |
|
$-0.29M |
|
$-0.26M |
|
170.42M |
|
170.42M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.60M |
|
$0.02M |
|
$0.11M |
|
$0.71M |
|
$3.02M |
|
-- |
|
-- |
|
$3.02M |
|
|
Common Equity |
$-2.31M |
$-2.35M |
|
$-2.31M |
|
170.42M |
|
| Cash Flow Statement Financials | |
$-0.21M |
|
-- |
|
$0.21M |
|
$0.01M |
|
$0.01M |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
12.77% |
|
12.56% |
|
-41.56% |
|
12.77% |
|
$-0.01 |
|
$-0.00 |
|
$-0.00 |
|